Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maro Ohanian

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Clinical Pharmacology : Advances and Applications|January 31, 2012
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case reportMaro Ohanian, Christian Cable, Kathleen Halka
Clinical Pharmacology : Advances and Applications|January 31, 2012
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndromeMaro Ohanian, Christian Cable, Kathleen Halka
British Journal of Haematology|March 16, 2019
Orbital extramedullary leukaemia is not a rare entity - response to PaydasMaro Ohanian, Cynthia Tung, Lynne V Abruzzo
Leukemia & Lymphoma|September 11, 2012
The role of clofarabine in acute myeloid leukemiaHady Ghanem, Hagop Kantarjian, Maro Ohanian, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
Rituximab in severe skin diseases: target, disease, and doseDaniel D Bennett, Maro Ohanian, Christian T Cable
Expert Opinion on Pharmacotherapy|April 24, 2012
Tyrosine kinase inhibitors in acute and chronic leukemiasMaro Ohanian, Jorge Cortes, Hagop Kantarjian, et al.
Expert Opinion on Pharmacotherapy|March 21, 2012
Treatment options for chronic myeloid leukemiaMaria Florencia Tanaka, Hagop Kantarjian, Jorge Cortes, et al.
Cancer Medicine|March 29, 2014
Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemiaUri Rozovski, Ping Li, David Harris, et al.
Expert Opinion on Biological Therapy|March 17, 2015
Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin's lymphomasMaro Ohanian, Hagop Kantarjian, Daniel Guy, et al.
International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Clinical Pharmacology : Advances and Applications|January 31, 2012
Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case reportMaro Ohanian, Christian Cable, Kathleen Halka
Clinical Pharmacology : Advances and Applications|January 31, 2012
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndromeMaro Ohanian, Christian Cable, Kathleen Halka
British Journal of Haematology|March 16, 2019
Orbital extramedullary leukaemia is not a rare entity - response to PaydasMaro Ohanian, Cynthia Tung, Lynne V Abruzzo
Leukemia & Lymphoma|September 11, 2012
The role of clofarabine in acute myeloid leukemiaHady Ghanem, Hagop Kantarjian, Maro Ohanian, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
Rituximab in severe skin diseases: target, disease, and doseDaniel D Bennett, Maro Ohanian, Christian T Cable
Expert Opinion on Pharmacotherapy|April 24, 2012
Tyrosine kinase inhibitors in acute and chronic leukemiasMaro Ohanian, Jorge Cortes, Hagop Kantarjian, et al.
Expert Opinion on Pharmacotherapy|March 21, 2012
Treatment options for chronic myeloid leukemiaMaria Florencia Tanaka, Hagop Kantarjian, Jorge Cortes, et al.
Cancer Medicine|March 29, 2014
Interleukin-7 receptor-α gene mutations are not detected in adult T-cell acute lymphoblastic leukemiaUri Rozovski, Ping Li, David Harris, et al.
Expert Opinion on Biological Therapy|March 17, 2015
Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin's lymphomasMaro Ohanian, Hagop Kantarjian, Daniel Guy, et al.
International Journal of Cancer|January 3, 2013
Is acute myeloid leukemia a liquid tumor?Maro Ohanian, Stefan Faderl, Farhad Ravandi, et al.
Pageof 10